Form 4: Evogene Director Buys Shares
Insider Transaction (Form 4)
Leon Recanati, a Director of Evogene Ltd., purchased 460,000 shares of common stock on August 11, 2026 for $0.64 per share.
Summary
- Open-market purchase: acquired 460,000 Ordinary Shares at $0.64 ($292,100) on August 11, 2026; holds 1,343,886 after (Direct).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $292,100, committing personal capital to the stock.
Insider Transactions
Leon Recanati — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Open-market purchase | Ordinary Shares | 460,000 | $1 | $292.1K | 1,343,886 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Open-market purchase (460,000 shares) |
Keywords
insider transaction, Form 4, EVGN, Evogene Ltd., bullish, Leon Recanati
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.